Observational studyMedicine2021

Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study.

I-Chih Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.